Search Results Search Sort by RelevanceMost Recent Medicine and Society Nov 2004 Gatekeeping and the FDA's Role in Human Subjects Protection Daniel Carpenter, PhD The FDA bears the responsibility to monitor clinical trials and protect human subjects from harm. Virtual Mentor. 2004;6(11):512-514. doi: 10.1001/virtualmentor.2004.6.11.msoc1-0411. In the Literature Nov 2004 Determining Research through Underdetermined Treatment Abraham P. Schwab, PhD Paul Miller and Charles Weijer defend the concept of equipoise in medical research in a recent journal article. Virtual Mentor. 2004;6(11):488-489. doi: 10.1001/virtualmentor.2004.6.11.jdsc1-0411. State of the Art and Science Jun 2005 Recognition and Treatment of Depression Holly A. Swartz, MD A physician outlines the criteria for diagnosing clinical depression and the principle modes for treating the mental illness. Virtual Mentor. 2005;7(6):430-434. doi: 10.1001/virtualmentor.2005.7.6.cprl1-0506. Pagination First page « First Previous page ‹ Previous … Page 9 Page 10 Page 11 Page 12 Page 13 Page 14 Page 15 Page 16 Current page 17
Medicine and Society Nov 2004 Gatekeeping and the FDA's Role in Human Subjects Protection Daniel Carpenter, PhD The FDA bears the responsibility to monitor clinical trials and protect human subjects from harm. Virtual Mentor. 2004;6(11):512-514. doi: 10.1001/virtualmentor.2004.6.11.msoc1-0411.
In the Literature Nov 2004 Determining Research through Underdetermined Treatment Abraham P. Schwab, PhD Paul Miller and Charles Weijer defend the concept of equipoise in medical research in a recent journal article. Virtual Mentor. 2004;6(11):488-489. doi: 10.1001/virtualmentor.2004.6.11.jdsc1-0411.
State of the Art and Science Jun 2005 Recognition and Treatment of Depression Holly A. Swartz, MD A physician outlines the criteria for diagnosing clinical depression and the principle modes for treating the mental illness. Virtual Mentor. 2005;7(6):430-434. doi: 10.1001/virtualmentor.2005.7.6.cprl1-0506.